Interleukin-1 cluster gene polymorphisms and aneurysmal subarachnoid hemorrhage

Neurosurgery

Volumn 66, Issue 6, 2010, Pages 1058-1062

  Fontanella, Marco ^a   Rainero, Innocenzo ^a   Gallone, Salvatore ^a   Rubino, Elisa ^a   Fornaro, Riccardo ^a   Fenoglio, Pierpaola ^a   Valfrè, Walter ^a   Vaula, Giovanna ^a   Benevello, Chiara ^a   Ducati, Alessandro ^a   Pinessi, Lorenzo ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Cerebral aneurysms; Interleukin 1 gene cluster; Polymorphisms

Indexed keywords

GENOMIC DNA; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

ADULT; ARTICLE; BRAIN ARTERY ANEURYSM RUPTURE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; GLASGOW OUTCOME SCALE; HAPLOTYPE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; GLASGOW OUTCOME SCALE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; MULTIGENE FAMILY; POLYMORPHISM, GENETIC; RECEPTORS, INTERLEUKIN-1; SEVERITY OF ILLNESS INDEX; SUBARACHNOID HEMORRHAGE;

EID: 77953013079     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000369187.95163.5D     Document Type: Article

References (37)

1. Suarez JI, Tarr RW, Selman WR. Aneurysmal subarachnoid hemorrhage. N Engl J Med. 2006;354(4):387-396.
2. Bederson JB, Awad IA, Wiebers DO, et al. Recommendations for the management of patients with unruptured intracranial aneurysms: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke. 2000;31(11):2742-2750.
3. Säveland H, Hillman J, Brandt L, Edner G, Jakobsson KE, Algers G. Overall outcome in aneurysmal subarachnoid hemorrhage. A prospective study from neurosurgical units in Sweden during a 1-year period. J Neurosurg. 1992;76(5):729-734.
4. Bradac GB, Bergui M, Stura G, et al. Periprocedural morbidity and mortality by endovascular treatment of cerebral aneurysms with GDC: a retrospective 12-year experience of a single center. Neurosurg Rev. 2007;30(2):117-126.
5. Graves EJ. Detailed diagnoses and procedures, national hospital discharge survey, 1990. Vital Health Stat 13. 1992; (113) : 1-225.
6. Moriwaki T, Takagi Y, Sadamasa N, Aoki T, Nozaki K, Hashimoto N. Impaired progression of cerebral aneurysms in interleukin-1beta-deficient mice. Stroke. 2006;37(3):900-905.
7. Chyatte D, Bruno G, Desai S, Todor DR. Inflammation and intracranial aneurysms. Neurosurgery. 1999;45(5):1137-1147.
8. Kataoka K, Taneda M, Asai T, Kinoshita A, Ito M, Kuroda R. Structural fragility and inflammatory response of ruptured cerebral aneurysms. A comparative study between ruptured and unruptured cerebral aneurysms. Stroke. 1999;30(7):1396-1401.
9. Tulamo R, Frösen J, Junnikkala S, et al. Complement activation associates with saccular cerebral artery aneurysm wall degeneration and rupture. Neurosurgery. 2006;59(5):1069-1077.
10. Ryba M, Grieb P, Podobińska I, Iwańska K, Pastuszko M, Górski A. HLA antigens and intracranial aneurysms. Acta Neurochir (Wien). 1992;116(1):1-5.
11. Hendryk S, Jarzab B, Josko J. Increase of the IL-1 beta and IL-6 levels in CSF in patients with vasospasm following aneurysmal SAH. Neuro Endocrinol Lett. 2004; 25 (1-2) : 141-147.
12. Kwon KY, Jeon BC. Cytokine levels in cerebrospinal fluid and delayed ischemic deficits in patients with aneurysmal subarachnoid hemorrhage. J Korean Med Sci. 2001;16(6):774-780.
13. Fontanella M, Rainero I, Gallone S, et al. Tumor necrosis factor-alpha gene and cerebral aneurysms. Neurosurgery. 2007;60(4):668-673.
14. Morgan L, Cooper J, Montgomery H, Kitchen N, Humphries SE. The interleukin-6 gene-174G>C and-572G>C promoter polymorphisms are related to cerebral aneurysms. J Neurol Neurosurg Psychiatry. 2006;77(8):915-917.
15. Ruigrok YM, Slooter AJ, Bardoel A, Frijns CJ, Rinkel GJ, Wijmenga C. Genes and outcome after aneurysmal subarachnoid haemorrhage. J Neurol. 2005;252(4):417-422.
16. Hall SK, Perregaux DG, Gabel CA, et al. Correlation of polymorphic variation in the promoter region of the interleukin-1 beta gene with secretion of interleukin-1 beta protein. Arthritis Rheum. 2004;50(6):1976-1983.
17. Basu A, Krady JK, Levison S W. Interleukin-1: a master regulator of neuroinflammation. J Neurosci Res. 2004;78(2):151-156.
18. Rothwell NJ, Luheshi GN. Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci. 2000;23(12):618-625.
19. Chen H, Wilkins LM, Aziz N, et al. Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet. 2006;15(4):519-529.
20. Shirodaria S, Smith J, McKay IJ, Kennet CN, Hughes FJ. Polymorphisms in the IL-1A gene are correlated with levels of interlukin-1alpha protein in gingival cervicular fluid of teeth with severe periodontal disease. J Dent Res. 2000;79(11):1864-1869.
21. Dziedzic T, Slowik A, Pera J, Szczudlik A. Interleukin 1 beta polymorphism (-511) and risk of stroke due to small vessel disease. Cerebrovasc Dis. 2005;20(5):299-303.
22. Grimaldi LM, Casadei VM, Ferri C, et al. Association of early-onset Alzheimer's disease with an interleukin-1 α gene polymorphism. Ann Neurol. 2000;47(3):361-365.
23. Huang DR, Pirskanene R, Hjelmström P, Lefvert AK. Polymorphisms in IL-1β and IL-1 receptor antagonist genes are associated with myasthenia gravis. J Neuroimmunol. 1998; 81 (1-2) : 76-81.
24. McGeer PL, McGeer EG. Polymorphisms in inflammatory genes and the risk of Alzheimer disease. Arch Neurol. 2001;58(11):1790-1792.
25. Fisher CM, Kistler J P, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery. 1980;6(1):1-9.
26. Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg. 1968;28(1):14-20.
27. Lindegaard K F, Nornes H, Bakke SJ, Sorteberg W, Nakstad P. Cerebral vasospasm after subarachnoid hemorrhage investigated by means of transcranial Doppler ultrasound. Acta Neurochir Suppl (Wien). 1998;42:81-84.
28. Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet. 1975;1(7905):480-484.
29. Nishimura M, Mizuta I, Mizuta E, Yamasaki S, Ohta M, Kuno S. Influence of interleukin-1β gene polymorphism on age-at-onset of sporadic Parkinson's disease. Neurosci Lett. 2000; 284 (1-2) : 73-76.
30. Bird TD, Jarvik G P, Wood N W. Genetic association studies: genes in search of diseases. Neurology. 2001;57(7):1153-1154.
31. Smith AJ, Keen LJ, Billingham MJ, et al. Extended haplotypes and linkage disequilibrium in the IL1R1-IL1A-IL1B-IL1RN gene cluster: association with knee osteoarthritis. Genes Immun. 2004;5(6):451-460.
32. Slowik A, Borratynska A, Turaj W, et al. Interleukin 1beta-511 C/T polymorphism and risk of aneurismal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2006;77(2):279-280.
33. Kim H, Hysi PG, Pawlikowska L, et al. Common variants in interleukin-1-Beta gene are associated with intracranial hemorrhage and susceptibility to brain arteriovenous malformation. Cerebrovasc Dis. 2009;27(2):176-182.
34. Jayaraman T, Berenstein V, Li X, et al. Tumor necrosis factor alpha is a key modulator of inflammation in cerebral aneurysms. Neurosurgery. 2005;57(3):558-564.
35. Tracy KJ, Cerami A. Tumor necrosis factor, other cytokines and disease. Ann Rev Cell Biol. 1993;9:317-343.
36. El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature. 2000;404(6776):398- 402.
37. Pociot F, Mølgiv J, Wogensen L, Worsaae H, Nerup J. A Taql polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest. 1992;22(6):396-402.